Giulia Ganzetti Selected Research

pidobenzone

1/2016

Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giulia Ganzetti Research Topics

Disease

10	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2018 - 01/2010
4	Necrosis 09/2016 - 01/2010
3	Melanoma (Melanoma, Malignant) 01/2019 - 06/2015
3	Skin Diseases (Skin Disease) 02/2018 - 01/2010
3	Inflammation (Inflammations) 12/2015 - 01/2015
2	Cutaneous Malignant Melanoma 01/2018 - 06/2015
2	Nevus (Nevi) 01/2018 - 06/2015
2	Mycosis Fungoides 01/2016 - 01/2009
2	Vitiligo 11/2010 - 01/2010
1	Neoplasms (Cancer) 01/2018
1	Lentigo (Lentiginosis) 01/2016
1	Hyperpigmentation 01/2016
1	Oral Lichen Planus 12/2015
1	Atherosclerosis 07/2015
1	Obesity 07/2015
1	Pigmented Nevus (Melanocytic Nevus) 06/2015
1	Alcoholic Fatty Liver 03/2015
1	Fibrosis (Cirrhosis) 03/2015
1	End Stage Liver Disease 03/2015
1	Non-alcoholic Fatty Liver Disease 03/2015
1	Alopecia Areata 01/2015
1	Cicatrix (Scar) 01/2015
1	Alopecia (Baldness) 01/2015
1	Rosacea (Acne Rosacea) 03/2014
1	Elastosis perforans serpiginosa 01/2014
1	Porokeratosis (Palmoplantar Porokeratosis) 09/2011
1	Keloid 09/2010
1	Hypertrophic Cicatrix (Hypertrophic Scar) 09/2010

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2015
3	CytokinesIBA 01/2017 - 01/2010
3	Etanercept (Enbrel)FDA Link 09/2016 - 01/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 01/2010
2	Nicotinamide N-MethyltransferaseIBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2016 - 09/2010
2	Infliximab (Remicade)FDA Link 01/2016 - 01/2016
2	OsteopontinIBA 12/2015 - 01/2015
2	AllantoinIBA 01/2014 - 09/2010
1	EnzymesIBA 01/2018
1	N-nitroso-N-methyltyramine (NNMT)IBA 01/2018
1	InterleukinsIBA 09/2016
1	pidobenzoneIBA 01/2016
1	Ustekinumab (CNTO 1275)FDA Link 01/2016
1	Adalimumab (Humira)FDA Link 01/2016
1	SurvivinIBA 12/2015
1	Interleukin-6 (Interleukin 6)IBA 07/2015
1	AdipokinesIBA 07/2015
1	ResistinIBA 07/2015
1	Nicotinamide PhosphoribosyltransferaseIBA 07/2015
1	AdiponectinIBA 07/2015
1	LeptinIBA 07/2015
1	Interleukin-17 (Interleukin 17)IBA 06/2015
1	Interleukin-23 (Interleukin 23)IBA 06/2015
1	Triglycerides (Triacylglycerol)IBA 03/2015
1	Urea (Carbamide)FDA LinkGeneric 01/2015
1	Vitamin D FDA LinkGeneric 11/2014
1	TetracyclinesIBA 03/2014
1	azelaic acid (Azelex)FDA Link 03/2014
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2014
1	SteroidsIBA 01/2014
1	diphenylcyclopropenoneIBA 11/2010
1	Chemokine CCL27IBA 01/2009

Therapy/Procedure

5	Therapeutics 01/2018 - 01/2010
3	Biological Therapy 02/2018 - 01/2016
2	Phototherapy (Light Therapy) 01/2015 - 11/2010
1	Immunotherapy 01/2018
1	Aftercare (After-Treatment) 09/2016
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2016
1	Cryotherapy (Therapy, Cold) 01/2016
1	Gas Lasers 01/2016
1	Intralesional Injections 01/2014
1	Off-Label Use 09/2011
1	Photochemotherapy (Photodynamic Therapy) 09/2011
1	PUVA Therapy 01/2009